Skip to main content
Erschienen in: Diabetes Therapy 6/2018

Open Access 06.10.2018 | Correction

Correction to: Reassessing Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus: A Brief Updated Analytical Report (2015–2017)

verfasst von: Xia Dai, Zu-chun Luo, Lu Zhai, Wen-piao Zhao, Feng Huang

Erschienen in: Diabetes Therapy | Ausgabe 6/2018

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The original article can be found online at https://​doi.​org/​10.​1007/​s13300-018-0504-3.

Correction to: Diabetes Ther https://​doi.​org/​10.​1007/​s13300-018-0504-3

In the original publication, Conclusion was incorrectly updated in the article main text. The complete statement is given below.
Conclusions
Mortality (1–5 years) did not significantly differ between the CABG and PCI patients with T2DM. However, rates of other major adverse events were significantly higher in the PCI patients, suggesting that CABG is more advantageous than PCI in patients with T2DM.

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://​creativecommons.​org/​licenses/​by-nc/​4.​0/​), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Correction to: Reassessing Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus: A Brief Updated Analytical Report (2015–2017)
verfasst von
Xia Dai
Zu-chun Luo
Lu Zhai
Wen-piao Zhao
Feng Huang
Publikationsdatum
06.10.2018
Verlag
Springer Healthcare
Erschienen in
Diabetes Therapy / Ausgabe 6/2018
Print ISSN: 1869-6953
Elektronische ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-018-0520-3

Weitere Artikel der Ausgabe 6/2018

Diabetes Therapy 6/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.